SFTBF News and Press, Softbank Corp Fgn From 03/23/23

2023-03-23 14:17:31 ET Shares of biotech firm Roivant Sciences ( NASDAQ: ROIV ) lost ~6% on Thursday to reach the lowest level since December after SoftBank Vision Fund, one of its major institutional investors, sold $96M worth of company shares. SVF, the flagship inve...

2023-03-07 17:11:26 ET WeWork ( NYSE: WE ) stock advanced as much as 8.8% in extended trading on Tuesday as the struggling flexible office space provider talked with potential investors about restructuring its more than $3B of outstanding debt as well as raising additional c...

Summary This is the second part of our 4-part series on High-Growth Industries. Robotic Process Automation (RPA) is expected to be adopted swiftly and drive tremendous growth for the software and automation industry. AR and VR are the most anticipated industries we will talk about i...

Summary SoftBank relies on speculation-friendly markets due to their investments in pre-IPO tech companies. As one of the best, and only, ways to gain exposure to start-ups, investors can consider an investment in the firm. However, the market is currently unfavorable for the conglo...

SoftBank Group Corp. (SFTBY) Q3 2023 Earnings Conference Call February 07, 2023, 02:30 AM ET Company Participants Yoshimitsu Goto - Board Director and CFO Kazuko Kimiwada - SVP, Head of Accounting Unit Navneet Govil - CFO, Member of the Executive Committee, SB Global A...

Summary VPL's portfolio is highly diversified, invests significantly in sectors with high growth potential, has a low expense ratio, and is trading at a marginal discount. Though VPL's current yield is not excessively high, it seems to be sustainable and the fund generates a high enough...

Summary Chase Coleman’s 13F portfolio value decreased from $11.93B to $10.90B this quarter. Tiger Global added HubSpot and increased ServiceNow, Alphabet, and Uber Technologies while reducing NU Holdings, CrowdStrike, and SentinelOne. The largest three positions are JD.com, M...

SoftBank Group Corp. (SFTBY) Q2 2023 Results Conference Call November 11, 2022 02:30 AM ET Company Participants Yoshimitsu Goto - Board Director and CFO Kazuko Kimiwada - SVP, Head of Accounting Unit Navneet Govil - Managing Partner and CFO, SoftBank Investment A...

Summary The FDA is working with congress to extend its regulatory arm over the gene testing market. Veracyte's products are marketed as LDTs and are not approved by the FDA. Regulatory risk weighs against Veracyte's relatively low cash burn and robust balance sheet, underpinni...

Summary DTH invests in high yield stocks of developed countries, excluding North America. 52% of assets is in 3 countries: Japan, the U.K. and Australia. 54% is in 3 sectors: financials, materials and communication. Valuation looks attractive, but inflation-adjusted total ...